Personal Finance

Eaton Vance Tax-Advantaged Dividend Income Fund : EVT

EVT

Stock Data

$26.52

$0.64 (2.36%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Evotec SE, headquartered in Hamburg, Germany, is a leading partner in drug discovery and development for the global pharmaceutical and biotechnology sectors. With a focus on a wide range of therapeutic areas including diabetes, oncology, and rare diseases, Evotec collaborates with major industry names like Bayer, Pfizer, and Takeda Pharmaceuticals. The company, which transitioned from Evotec AG to Evotec SE in 2019, leverages its expertise to advance treatments from concept to clinical development, aiming to address complex health challenges.

All Eaton Vance Tax-Advantaged Dividend Income Fund Articles

1 Article

David Beren | May 17, 2026 at 9:38 AM EDT

Kiplinger’s May 2026 Letter Says Yields From 3% to 13% Are Available Right Now Despite Iran War Uncertainty

Kiplinger’s Personal Finance May 2026 letter makes it clear that if you are looking for yield, the door is wide…